Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ando T et al. – The findings show that extended survival is possible after EM relapse following allo–HSCT in patients with marrow hematopoiesis of donor origin, and that augmentation of the graft–versus–leukemia effect may be useful.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address